Intrinsiqs

Is United Therapeutics Corporation overvalued?

United Therapeutics Corporation (UTHR) looks overvalued — trading about 10% above its fair value.

Overvalued
Current price $475.45 Fair value $429.99
Price
$475.45
Fair value
$429.99
Current P/E
17.6
Normal P/E
15.9
Market cap
$20.18B
Dividend yield
0.0%
Return on equity
20.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares UTHR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated